Related Experiment Videos

Group B streptococcus. Is it time for a screening program?

B A Paes1

  • 1St Joseph's Hospital, Hamilton, Ont.

Canadian Family Physician Medecin De Famille Canadien
|February 1, 1995
PubMed

Insights

Group B streptococcus (GBS) infections cause serious perinatal sepsis. Current diagnostic and intervention strategies show limited success, and screening is not widely implemented.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Group B streptococcal (GBS) infection is a significant cause of perinatal sepsis.
  • Early diagnosis relies on clinical suspicion and laboratory findings.
  • Existing interventions during pregnancy and childbirth have yielded limited success.

Purpose of the Study:

  • To review the challenges in diagnosing and managing Group B streptococcal infections in newborns.
  • To evaluate the effectiveness of current and proposed interventions.
  • To discuss the implications of limited screening adoption.

Main Methods:

  • Literature review of studies on GBS infection, diagnosis, and management.
  • Analysis of intervention strategies across antepartum, intrapartum, and postpartum periods.
  • Examination of screening adoption rates and challenges.

Main Results:

  • Perinatal sepsis due to GBS remains a critical issue.
  • Diagnostic methods require high clinical suspicion and laboratory confirmation.
  • Interventions have shown limited efficacy.
  • Screening for GBS has not been widely adopted.

Conclusions:

  • Effective strategies for preventing GBS-related perinatal sepsis are still needed.
  • Further research into improved diagnostic tools and widely adopted screening protocols is essential.
  • Addressing the challenges in GBS management is crucial for neonatal health.

Related Concept Videos